Literature DB >> 11874416

Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients.

Liliana B Dain1, Noemí D Buzzalino, Adriana Oneto, Susana Belli, Mirta Stivel, Titania Pasqualini, Carolina Minutolo, Eduardo H Charreau, Liliana G Alba.   

Abstract

OBJECTIVE: To characterize the molecular basis of the 21-hydroxylase deficiency in a group of Argentine patients presenting the classical and nonclassical forms of the disease.
DESIGN: To analyse the frequency of point mutations in the CYP21 gene by DNA amplification and mutation detection. PATIENTS: Forty-one patients from 36 nonrelated families: 25 nonclassical (NC), 11 salt-wasting (SW) and five simple virilizing (SV). A total of 27 parents and 13 nonaffected siblings were also analysed. MEASUREMENTS: Basal steroid hormones and 17-hydroxyprogesterone levels following adrenal stimulation with adrenocorticotrophic hormone were measured, together with an analysis of 10 point mutations in the CYP21 gene.
RESULTS: A total of 83% and 74.4% classical and nonclassical chromosomes, respectively, were characterized. The intron 2 mutation was the most prevalent among classical alleles. In addition, a high frequency for R356W was observed in both groups (13.3 and 6.9%, respectively), while V281L was the most frequent mutation among the nonclassical patients with a frequency of 39.5%. No alleles containing P30L were observed, and one de novo mutation (R356W) was found. A total of 68.3% patients were fully genotyped, and all but one showed no genotype/phenotype discrepancy. Though the cut-off value for post-ACTH 17-hydroxyprogesterone stimulation was 30.25 nmol/l (10.00 microg/l), the lowest value observed in the fully genotyped nonclassical group was 42.35 nmol/l (14.00 microg/l).
CONCLUSIONS: The high number of unidentified alleles in the nonclassical group suggests that less frequent mutations, or the presence of new ones, might be the cause of the disease in the Argentine population. Alternatively, the cut-off value in the ACTH-stimulated 17-hydroxyprogesterone test might overestimate the diagnosis of the nonclassical form by including some patients with heterozygous status.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874416     DOI: 10.1046/j.0300-0664.2001.01419.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Misregulation effect of a novel allelic variant in the Z promoter region found in cis with the CYP21A2 p.P482S mutation: implications for 21-hydroxylase deficiency.

Authors:  Cecilia S Fernández; Carlos D Bruque; Melisa Taboas; Noemí D Buzzalino; Lucia D Espeche; Titania Pasqualini; Eduardo H Charreau; Liliana G Alba; Pablo D Ghiringhelli; Liliana Dain
Journal:  Endocrine       Date:  2015-07-17       Impact factor: 3.633

2.  Genotype, phenotype and hormonal levels correlation in non-classical congenital adrenal hyperplasia.

Authors:  S Einaudi; E Napolitano; F Restivo; G Motta; M Baldi; G Tuli; E Grosso; N Migone; E Menegatti; C Manieri
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

3.  Molecular diagnosis of Chinese patients with 21-hydroxylase deficiency and analysis of genotype-phenotype correlations.

Authors:  Bo Zhang; Lin Lu; Zhaolin Lu
Journal:  J Int Med Res       Date:  2017-02-02       Impact factor: 1.671

4.  Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.

Authors:  I Milacic; M Barac; T Milenkovic; M Ugrin; K Klaassen; A Skakic; M Jesic; I Joksic; K Mitrovic; S Todorovic; S Vujovic; S Pavlovic; M Stojiljkovic
Journal:  J Endocrinol Invest       Date:  2015-08-02       Impact factor: 4.256

Review 5.  Parents of children with autosomal recessive diseases are not always carriers of the respective mutant alleles.

Authors:  Joel Zlotogora
Journal:  Hum Genet       Date:  2004-03-16       Impact factor: 4.132

6.  Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients.

Authors:  Carolina Minutolo; Alejandro D Nadra; Cecilia Fernández; Melisa Taboas; Noemí Buzzalino; Bárbara Casali; Susana Belli; Eduardo H Charreau; Liliana Alba; Liliana Dain
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

7.  CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.

Authors:  Firdevs Baş; Hülya Kayserili; Feyza Darendeliler; Oya Uyguner; Hülya Günöz; Memnune Yüksel Apak; Fatmahan Atalar; Rüveyde Bundak; Robert C Wilson; Maria I New; Bernd Wollnik; Nurçin Saka
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-02

8.  Isolated p.H62L Mutation in the CYP21A2 Gene in a Simple Virilizing 21-Hydroxylase Deficient Patient.

Authors:  Melisa Taboas; Cecilia Fernández; Susana Belli; Noemi Buzzalino; Liliana Alba; Liliana Dain
Journal:  Case Rep Genet       Date:  2013-07-07

9.  Functional studies of p.R132C, p.R149C, p.M283V, p.E431K, and a novel c.652-2A>G mutations of the CYP21A2 gene.

Authors:  Melisa Taboas; Luciana Gómez Acuña; María Florencia Scaia; Carlos D Bruque; Noemí Buzzalino; Mirta Stivel; Nora R Ceballos; Liliana Dain
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.